Coca-Cola Raises Full-Year Profit Forecast After Strong Q1 2026 Beat
Coca-Cola beat earnings, grew sales and profit, raised its outlook, and is selling more drinks worldwide.
Already have an account? Sign in.
Coca-Cola beat earnings, grew sales and profit, raised its outlook, and is selling more drinks worldwide.
Ardelyx shares fell after losing a court case on Xphozah Medicare coverage, moving drug into bundled payments, hurting revenue outlook.
BTIG is bullish on Robinhood, seeing strong growth, young users, rising trading activity, and a $125 price target.
Piper Sandler raised its price target on Moderna from $69 to $77, maintaining an Overweight rating. Strong momentum in the oncology pipeline is fueling the rally.